Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer

Oncotarget

Volumn 7, Issue 17, 2016, Pages 24677-24687

  Kyung A Hyun, ^a   Goo, Ki Bang ^b   Han, Hyunju ^c   Sohn, Joohyuk ^c   Choi, Wonshik ^d   Kim, Seung Il ^c   Jung, Hyo Il ^a   Kim, You Sun ^b  

^a Yonsei University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Korea University   (South Korea)

Author keywords

Circulating tumor cells (CTCs); EMT induced breast cancer cell; EpCAM negative; Epithelial cell adhesion molecule (EpCAM); Label free separation

Indexed keywords

CD133 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; UVOMORULIN; EPCAM PROTEIN, HUMAN;

ARTICLE; BREAST METASTASIS; CANCER RESISTANCE; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MICROSCOPY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; FEMALE; GENETICS; MCF-7 CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; TUMOR EMBOLISM;

BREAST NEOPLASMS; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MCF-7 CELLS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84966473543     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8250     Document Type: Article

References (25)

1. Cristofanilli M, Hayes DF, Budd GT, Ellis M J, Stopeck A, Reuben J M, Doyle G V, Matera J, Allard W J, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 2005; 23: 1420-1430.
2. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 2007; 13: 920-928.
3. Witzig TE, Bossy B, Kimlinger T, Roche PC, Ingle JN, Grant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Detection of circulating cytokeratinpositive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscop. Clin. Cancer Res. 2002; 8: 1085-1091.
4. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331: 1559-1164.
5. Gorges TM, Pantel K. Circulating tumor cells as therapyrelated biomarkers in cancer patients. Cancer Immunol, Immunother. 2013; 62: 931-939.
6. Gorges TM, Tinhofer I, Drosch M, Rose L, Zollner TM, Krahn T, von Ahsen O. Circulating tumour cells escape from EpCAM-based detection due to epithelial-tomesenchymal transition. BMC Cancer. 2012; 12: 178.
7. Helzer KT, Barnes HE, Day L, Harvey J, Billings PR, Forsyth A. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model. Cancer Res. 2009; 69: 7860-7866.
8. Hyun KA, Jung HI. Microfluidic devices for the isolation of circulating rare cells: A focus on affinity-based, dielectrophoresis, and hydrophoresis. Electrophoresis. 2013; 34: 1028-1041.
9. Hyun KA, Jung HI. Advances and critical concerns with the microfluidic enrichments of circulating tumor cells. Lab. Chip. 2014; 14: 45-56.
10. Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol. Med. 2015; 7: 1-11.
11. Hyun KA., Kwon K, Han H, Kim SI., Jung HI. Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients. Biosens Bioelectron. 2013; 40: 206-212.
12. Kim YJ, Koo GB, Lee JY, Moon HS, Kim DG, Lee DG, Lee JY, Oh JH, Park JM, Kim MS, Woo HG, Kim SI, Kang P, Choi W, Sim TS, Park WY, Lee JG, Kim YS. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads. Biomaterials. 2014; 35: 7501-7510.
13. Kim YS, Morgan MJ, Choksi S, Liu ZG. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell. 2007; 26: 675-687.
14. Bachelard-Cascales E, Chapellier M, Delay E, Maguer-Satta V. Protocol to Quantify Mammary Early Common Progenitors from Long-Term Mammosphere Culture. Curr. Protoc. Stem Cell Biol. John Wiley & Sons, Inc. IE.7.1-IE.7.6, 2012.
15. Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M, Baehring F, Voigt K, Lazar D, Nieva J, Bazhenova L, Ko AH, Korn WM, Schram E, Coward M, Yang X, Metzner T, Lamy R, Honnatti M, Yoshioka C, Kunken J, Petrova Y, Sok D, Nelson D, Kuhn P. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys. Biol. 2012; 9: 016003.
16. Choi Y, Yang TD, Lee KJ, Choi W. Full-field and singleshot quantitative phase microscopy using dynamic speckle illumination. Opt. Lett. 2011; 36: 2465-2467.
17. Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, Taylor-Papadimitriou J, Burchell JM. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 2008; 10: R52.
18. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, Woodward WA. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One. 2010; 5: e12180.
19. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang C C., Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-715.
20. Geng SQ, Alexandrou AT, Li JJ. Breast cancer stem cells: Multiple capacities in tumor metastasis. Cancer Lett. 2014; 349: 1-7.
21. Coumans FA, Ligthart ST, Uhr JW, Terstappen LW. Challenges in the enumeration and phenotyping of CTC. Clin. Cancer Res. 2012; 18: 5711-5718.
22. de Albuquerque A, Kaul S, Breier G, Krabisch P, Fersis N. Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine. Breast Care (Basel). 2012; 7: 7-12.
23. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008; 68: 989-997.
24. Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs. Breast Cancer Res. Treat. 2012; 132: 75-85.
25. Popescu G, Park Y, Lue N, Best-Popescu C, Deflores L, Dasari RR, Feld MS, Badizadegan K. Optical imaging of cell mass and growth dynamics. Am. J. Physiol. Cell Physiol. 2008; 295: C538-C544.